apixaban
Showing 1 - 25 of 153
Atrial Fibrillation Trial in Seoul (Apixaban)
Active, not recruiting
- Atrial Fibrillation
- Apixaban
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National university Hostpital
Mar 16, 2023
Venous Thromboembolism Trial in Valhalla (Apixaban)
Completed
- Venous Thromboembolism
- Apixaban
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Spinal Cord Injuries, Spinal Diseases Trial (Apixaban, Enoxaparin Sodium)
Not yet recruiting
- Spinal Cord Injuries
- Spinal Diseases
- Apixaban
- Enoxaparin Sodium
- (no location specified)
Aug 1, 2022
Bariatric Surgery and Pharmacokinetics of Apixaban
Recruiting
- Obesity, Morbid
- Apixaban
-
Trondheim, NorwaySt. Olavs University Hospital
Mar 14, 2022
Intrahepatic Non Cirrhotic Portal Hypertension Trial in Clichy (Apixaban, Placebo)
Recruiting
- Intrahepatic Non Cirrhotic Portal Hypertension
- Apixaban
- Placebo
-
Clichy, FranceBeaujon hospital
Mar 21, 2022
Trial in Philadelphia (Apixaban)
Available
- Apixaban
-
Philadelphia, PennsylvaniaChildrens Hospital Of Philadelphia
Mar 7, 2022
Glioblastoma, Astrocytoma, Venous Thromboembolism Trial (Apixaban)
Not yet recruiting
- Glioblastoma
- +2 more
- Apixaban
- (no location specified)
Jan 4, 2023
COVID-19 Trial in Rawalpindi (Apixaban, Rivaroxaban)
Not yet recruiting
- COVID-19
- Apixaban
- Rivaroxaban
-
Rawalpindi, Punjab, PakistanRawalpindi Medical University
Feb 22, 2022
Left Ventricular Thrombus Trial in Dammam (Apixaban, Warfarin)
Completed
- Left Ventricular Thrombus
- Apixaban
- Warfarin
-
Dammam, Saudi ArabiaSaud AlBabtain Cardiac Center
Jan 12, 2022
Heart Failure Trial in Falls Church (Apixaban, Warfarin, LVAD implant)
Recruiting
- Heart Failure
- Apixaban
- +2 more
-
Falls Church, VirginiaInova Fairfax Medical Campus
Feb 21, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Apixaban
-
Lexington, Kentucky
- +2 more
Jun 6, 2022
Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- +2 more
- Rivaroxaban (Xarelto, BAY59-7939)
- Apixaban
-
Wuppertal, GermanyBayer
Jul 25, 2022
Patterns Among Venous Thromboembolism in the United States
Active, not recruiting
- Venous Thromboembolism
- apixaban
- warfarin
-
New York, New YorkPfizer
Mar 29, 2023
(Called RETAF-PS) UsingPatient Survey to Learn More About
Not yet recruiting
- Prevention of Thromboembolic Events
- Atrial Fibrillation
- Apixaban
-
Whippany, New JerseyBayer
Jul 21, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)
Recruiting
- Atrial Fibrillation
- Apixaban
- Rivaroxaban
-
Ottawa, Ontario, CanadaThe Ottawa Hospital - General Campus
Mar 14, 2022
Pancreas Cancer, DVT, Pulmonary Embolism Trial in Philadelphia (Apixaban)
Completed
- Pancreas Cancer
- +2 more
- Apixaban
-
Philadelphia, PennsylvaniaThomas Jefferson University Clinical Research Unit
Dec 6, 2021
Venous Thromboembolism Trial in Canada (Apixaban, Rivaroxaban)
Completed
- Venous Thromboembolism
- Apixaban
- Rivaroxaban
-
Edmonton, Alberta, Canada
- +3 more
Mar 21, 2022
Prophylactic and Therapeutic Anticoagulants in Egyptian COVID-19
Completed
- Covid19
- +2 more
- Enoxaparin
- +2 more
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Transient Ischemic Attack, Stroke, Atrial Fibrillation Trial in United States (Apixaban, Warfarin)
Completed
- Transient Ischemic Attack
- +2 more
- Apixaban
- Warfarin
-
Torrance, California
- +4 more
Nov 3, 2021
Anti-Xa Activity Trial in Vancouver (apixaban)
Terminated
- Anti-Xa Activity
- apixaban
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Jul 28, 2021
Nephrotic Syndrome, Thromboembolic Disease Trial in Aarhus (Dalteparin, Apixaban)
Recruiting
- Nephrotic Syndrome
- Thromboembolic Disease
- Dalteparin
- Apixaban
-
Aarhus, DenmarkAarhus University Hospital
May 20, 2022